Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome

Blood (2023) 141 (9): 971–983.

https://doi.org/10.1182/blood.2022018546

Published: 2023

Includes: Supplemental data

Journal Articles

Circulating B-Cell Precursor Cells As Potential Diagnostic and Therapeutic Biomarker in Patients with WHIM Syndrome

Ulrich Salzer, Christoph B. Geier, Maryssa Ellison, Melis Yilmaz, Caroline von Spee-Mayer, Carsten Speckmann, Stephan Ehl, Olaf Neth, Ana Pilar Garcia Garcia, Angela Deya Martinez, Laia Alsina, Katja Sockel, Catharina Schuetz, David E. Potts, Boglarka Ujhazi, Krisztian Csomos, Jolan E. Walter, Klaus Warnatz

Blood (2022) 140 (Supplement 1): 2626–2627.

https://doi.org/10.1182/blood-2022-159190

Published: 2022

Journal Articles

Clinical, Immunological Features, Treatments, and Outcomes of Autoimmune Hemolytic Anemia in Patients with RAG Deficiency

Blood (2022) 140 (Supplement 1): 2448–2450.

https://doi.org/10.1182/blood-2022-162845

Published: 2022

Journal Articles

Interim Analysis of Safety and Hematological Parameters of an Ongoing Long-Term Open-Label Extension Study of Investigational PI3Kδ Inhibitor Leniolisib for Patients with Activated PI3K Delta Syndrome (APDS) through December 2021

V. Koneti Rao, Sharon Webster, Anna Sediva, Alessandro Plebani, Catharina Schuetz, Anna Shcherbina, Virgil A.S.H. Dalm, Antonino Trizzino, Yulia Zharankova, Elaine Kulm, Alanvin Orpia, Lavenda Chirombo Kluczynski, Julia Körholz, Vassilios Lougaris, Yulia Rodina, Klaus Kucher, Kath Radford, Jason Bradt, Gulbu Uzel

Blood (2022) 140 (Supplement 1): 1643–1645.

https://doi.org/10.1182/blood-2022-160334

Published: 2022

Journal Articles

Reticular dysgenesis: international survey on clinical presentation, transplantation, and outcome

Blood (2017) 129 (21): 2928–2938.

https://doi.org/10.1182/blood-2016-11-745638

Published: 2017

Includes: Supplemental data

Journal Articles

Wiskott-Aldrich Syndrome: A Retrospective Study on 575 Patients Analyzing the Impact of Splenectomy, Stem Cell Transplantation, or No Definitive Treatment on Frequency of Disease-Related Complications and Physician-Perceived Quality of Life

Jannik S Glasmacher, Tanja C Bittner, MD, Hans D Ochs, MD, Alessandro Aiuti, MD PhD, Peter D Arkwright, MD, Dmitry Balashov, Uta Behrends, Bernd H. Belohradsky, MD, Elisa Bertoni, David K. Buchbinder, MD MSHS, Michael Browning, Anastasiia Bondarenko, Fabio Candotti, MD, Alessandro Cattoni, Liudmyla Chernyshova, Joseph H. Chewning, MD, Peter Ciznar, Theresa Cole, Beatriz T Costa-Carvalho, Wojciech Czogala, Gregor Dueckers, David M Edgar, Fatih Erbey, Anders Fasth, MD PhD, Renata Formankova, MD PhD, Tomas Freiberger, Eleonora Gambineri, Andrew Gennery, MD, Frederick D Goldman, MD, Luis I Gonzalez-Granado, Tiago N Gulmaraes, David Hagin, MD PhD, Fabian Hauck, MD PhD, Tarja Heiskanen-Kosma, Manfred Hoenig, MD, Hanna Juntti, Hirokazu Kanegane, Leena Kainulainen, Neslihan E Karaca, Sara S Kilic, Christoph Klein, MD PhD, Sylwia Koltan, Irina Kondratenko, Dawei Liu, MD, Susanne Matthes, MD, Juliana T L Mazzucchelli, Isabelle Meyts, Siraj Misbah, Zohreh Nademi, Gulnara Nasrullayeva, Lucia D Notarangelo, Pere Soler-Palacin, Olga Pashchenko, Srdjan Pasic, Isabelle Pellier, MD, Claudio Pignata, Camilla Roepstorff, Catharina Schuetz, Ansgar S Schulz, MD PhD Prof., Gesmar R S Segundo, Anna Shcherbina, Joanne Smart, Robert A. Sokolic, MD, Polina Stepensky, MD, Troy Torgerson, MD PhD, Svetlana Vakhlyarskaya, Joris van Montfrans, MD PhD, Kim Vettenranta, MD PD, Beata Wolska-Kusnierz, Xiaodong Zhao, John B Ziegler, Xuan Zhang, Michael H. Albert, MD

Blood (2016) 128 (22): 366.

https://doi.org/10.1182/blood.V128.22.366.366

Published: 2016

Journal Articles

SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID

Blood (2014) 123 (2): 281–289.

https://doi.org/10.1182/blood-2013-01-476432

Published: 2014

Includes: Supplemental data

Journal Articles

Radioimmunotherapy-based conditioning for hematopoietic cell transplantation in children with malignant and nonmalignant diseases

Ansgar S. Schulz, Gerhard Glatting, Manfred Hoenig, Catharina Schuetz, Susanne A. Gatz, Simon Grewendorf, Monika Sparber-Sauer, Rainer Muche, Norbert Blumstein, Gabriele Kropshofer, Meinolf Suttorp, Donald Bunjes, Klaus-Michael Debatin, Sven N. Reske, Wilhelm Friedrich

Blood (2011) 117 (17): 4642–4650.

https://doi.org/10.1182/blood-2010-06-284349

Published: 2011

Includes: Supplemental data

Journal Articles

Radioimmunotherapy for Myeloablation Before SCT in Paediatric Patients with Malignant and Non-Malignant Diseases.

Ansgar S. Schulz, Susanne Gatz, Catharina Schuetz, Norbert Blumstein, Gerhard Glatting, Thomas Kull, Sven Reske, Klaus-Michael Debatin, Wilhelm Friedrich

Blood (2007) 110 (11): 624.

https://doi.org/10.1182/blood.V110.11.624.624

Published: 2007

Journal Articles

Compound Heterozygeous RAG-1 Mutations in 2 Patients Presenting with Chronic Disfiguring Granulomatous Skin Lesions.

Catharina Schuetz, MD, Sonja Gudowius, MD, Tim Niehues, MD, Ansgar Schulz, MD, Klaus Schwarz, MD, Klaus-Michael Debatin, Prof MD, Wilhelm Friedrich, Prof MD

Blood (2005) 106 (11): 3898.

https://doi.org/10.1182/blood.V106.11.3898.3898

Published: 2005

Journal Articles

Successful Allogeneic HSCT in a Patient with Chronic Granulomatous Disease and McLeod Phenotype after Sensitization to Kx- and K- Antigens.

Manfred Hoenig, Ansgar Schulz, Catharina Schuetz, Joachim Freihorst, Ulrich Baumann, Willy A. Flegel, Klaus-Michael Debatin, Wilhelm Friedrich

Blood (2005) 106 (11): 1439.

https://doi.org/10.1182/blood.V106.11.1439.1439

Published: 2005

Journal Articles

Treatment of Complete DiGeorge Syndrome by Repeat Transfusions of Blood Lymphocytes from an HLA-Identical Sibling Donor.

Manfred Hoenig, Ansgar Schulz, Catharina Schuetz, Klaus-Michael Debatin, Wilhelm Friedrich

Blood (2004) 104 (11): 1332.

https://doi.org/10.1182/blood.V104.11.1332.1332

Published: 2004

NARROW

A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome

Circulating B-Cell Precursor Cells As Potential Diagnostic and Therapeutic Biomarker in Patients with WHIM Syndrome

Clinical, Immunological Features, Treatments, and Outcomes of Autoimmune Hemolytic Anemia in Patients with RAG Deficiency

Interim Analysis of Safety and Hematological Parameters of an Ongoing Long-Term Open-Label Extension Study of Investigational PI3Kδ Inhibitor Leniolisib for Patients with Activated PI3K Delta Syndrome (APDS) through December 2021

Reticular dysgenesis: international survey on clinical presentation, transplantation, and outcome

Wiskott-Aldrich Syndrome: A Retrospective Study on 575 Patients Analyzing the Impact of Splenectomy, Stem Cell Transplantation, or No Definitive Treatment on Frequency of Disease-Related Complications and Physician-Perceived Quality of Life

SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID

Radioimmunotherapy-based conditioning for hematopoietic cell transplantation in children with malignant and nonmalignant diseases

Radioimmunotherapy for Myeloablation Before SCT in Paediatric Patients with Malignant and Non-Malignant Diseases.

Compound Heterozygeous RAG-1 Mutations in 2 Patients Presenting with Chronic Disfiguring Granulomatous Skin Lesions.

Successful Allogeneic HSCT in a Patient with Chronic Granulomatous Disease and McLeod Phenotype after Sensitization to Kx- and K- Antigens.

Treatment of Complete DiGeorge Syndrome by Repeat Transfusions of Blood Lymphocytes from an HLA-Identical Sibling Donor.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only